Impact of therapy of chronic hepatitis C (CHC) on quality of marital relationships

被引：0
|
作者：
O'Brien, Miechelle
Rosenthal, Lawrence S.
Lebovics, Edward
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A836 / A836
页数：1
相关论文
共 50 条
  • [41] Impact on sustained response and predictive factors of the different patterns of early virological response during therapy in naive patients with chronic hepatitis C (CHC)
    Garcia-Retortillo, Montserrat
    Gimenez, Maria Dolors
    Marquez, Carme
    Cirera, Isabel
    Coll, Susanna
    Bory, Felip
    Sola, Ricard
    HEPATOLOGY, 2007, 46 (04) : 375A - 375A
  • [42] Retreatment of chronic hepatitis C (CHC): outcomes and factors predicting outcomes
    Kong, J. Y.
    Kontorinis, N.
    Tarquinio, L.
    Nazareth, S.
    Mcinerney, M.
    Flexman, J.
    Cheng, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A133 - A133
  • [43] Impact of adherence on the outcome of antiviral therapy for chronic hepatitis C
    Mulhall, BP
    Younossi, Z
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (01) : S23 - S27
  • [44] Treatment of chronic hepatitis C: impact of combination therapy.
    Davis G.L.
    Current Gastroenterology Reports, 1999, 1 (1) : 9 - 14
  • [45] ASSESSMENT OF THE HEALTH-RELATED QUALITY-OF-LIFE (HQL) OF PATIENTS WITH CHRONIC HEPATITIS-C (CHC)
    WARE, JE
    BUNGAY, K
    GANDEK, B
    BAYLISS, M
    GASTROENTEROLOGY, 1994, 106 (04) : A33 - A33
  • [46] The impact of antiviral therapy for hepatitis C on the quality of life: a perspective
    Dusheiko, Geoffrey
    LIVER INTERNATIONAL, 2017, 37 : 7 - 12
  • [47] Antiviral combination therapy modulates serum levels of markers of hepatic angiogenesis in chronic hepatitis C (CHC) patients
    Salcedo-Mora, XB
    Sanz-Cameno, P
    Medina, J
    Martín-Vílchez, S
    Trapero-Marugán, M
    Moreno-Monteagudo, JA
    Borque, MJ
    Rodríguez-Salvanés, F
    Moreno-Otero, R
    HEPATOLOGY, 2005, 42 (04) : 663A - 663A
  • [48] The impact of body mass index (BMI) on liver histology and treatment tolerability and efficacy in chronic hepatitis C (CHC)
    Harvin, GK
    Miles, LG
    Huntley, NL
    Willner, IR
    Reuben, A
    GASTROENTEROLOGY, 2003, 124 (04) : A704 - A704
  • [49] TREATMENT BURDEN ASSOCIATED WITH PEGINTERFERON- BASED ANTIVIRAL THERAPY FOR PATIENTS WITH CHRONIC HEPATITIS C (CHC) IN JAPAN
    Kuwabara, H.
    VALUE IN HEALTH, 2013, 16 (03) : A98 - A99
  • [50] Impact of non-alcoholic fatty liver disease (NAFLD) on chronic hepatitis B (CHB) and C (CHC)
    Markova, A. A.
    Dragneva, S. S.
    Antonov, K.
    Jelev, D.
    Kosseva, O.
    Ivanova, R.
    Gegova, A.
    Mateva, L.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S355 - S355
12345